Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Successful Treatment of Interstitial Lung Disease in STAT3 Gain-of-Function Using JAK Inhibitors

11 May 2020

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cytokine Signaling Pathways and Interactions
Share to Immunodeficiency and Autoimmune Disorders
Share to Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32392079
DOI: 10.1164/rccm.201906-1204le

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Successful Treatment of Interstitial Lung Disease in STAT3 Gain-of-Function Using JAK InhibitorsPMID 32392079Read ↗

STAT3 Gain of Function: A New Kid on the Block in Interstitial Lung DiseasesSemantic proximity Read ↗

JAK-STAT signaling in human disease: From genetic syndromes to clinical inhibition.Semantic proximity Read ↗

The Goldilocks Principle of JAKs and STATs: Gain-of function mutations, loss-of-function mutations, and their clinical consequencesSemantic proximity Read ↗

The JAK/STAT conundrum with mutational heterogeneity, immune defects, and the emergence of targeted therapies.Semantic proximity Read ↗

JAK Inhibition in STAT1 Gain-of-Function–Mediated Treatment-Resistant Autoimmune HepatitisSemantic proximity Read ↗

Biological and clinical significance of the JAK-STAT pathway; lessons from knockout miceSemantic proximity Read ↗

Life-Saving, Dose-Adjusted, Targeted Therapy in a Patient with a STAT3 Gain-of-Function MutationSemantic proximity Read ↗

JAK inhibition in early-onset somatic, nonclonal STAT5B gain-of-function diseaseSemantic proximity Read ↗

JAKs and STATs from a Clinical Perspective: Loss-of-Function Mutations, Gain-of-Function Mutations, and Their Multidimensional ConsequencesSemantic proximity Read ↗

The JAK-STAT Pathway: Impact on Human Disease and Therapeutic InterventionSemantic proximity Read ↗

STAT3 Inhibitors: Finding a Home in Lymphoma and LeukemiaSemantic proximity Read ↗

JAKs and STATs in immunity, immunodeficiency, and cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.